Christopher J. Evans

13.0k total citations · 2 hit papers
184 papers, 10.2k citations indexed

About

Christopher J. Evans is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Christopher J. Evans has authored 184 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Cellular and Molecular Neuroscience, 93 papers in Molecular Biology and 45 papers in Physiology. Recurrent topics in Christopher J. Evans's work include Neuropeptides and Animal Physiology (103 papers), Receptor Mechanisms and Signaling (76 papers) and Pain Mechanisms and Treatments (39 papers). Christopher J. Evans is often cited by papers focused on Neuropeptides and Animal Physiology (103 papers), Receptor Mechanisms and Signaling (76 papers) and Pain Mechanisms and Treatments (39 papers). Christopher J. Evans collaborates with scholars based in United States, France and United Kingdom. Christopher J. Evans's co-authors include Duane E. Keith, Jack D. Barchas, Eckard Weber, Brigitte L. Kieffer, Mark von Zastrow, Karin Magendzo, Heather Morrison, Robert H. Edwards, Wendy Walwyn and Nigel T. Maidment and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher J. Evans

178 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning of a Delta Opioid Receptor by Functional Expression

1992 986 citations Christopher J. Evans et al. profile →
Regulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance

2013 624 citations Christopher J. Evans et al. profile →

Peers

Countries citing papers authored by Christopher J. Evans

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Evans more than expected).

Fields of papers citing papers by Christopher J. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Evans. The network helps show where Christopher J. Evans may publish in the future.

Co-authorship network of co-authors of Christopher J. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Evans. A scholar is included among the top collaborators of Christopher J. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Evans. Christopher J. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation 2024 ·Journal of Patient-Reported Outcomes ·Robert Farber, Donald E. Stull, (unknown), Christopher J. Evans, (unknown), (unknown), Rahul Dhanda, (unknown), (unknown)	2
2	Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial 2021 ·Translational Psychiatry ·Erica N. Grodin, Spencer Bujarski, (unknown), Elizabeth M. Burnette, Steven J. Nieto, Aaron C. Lim, Johnny Wei‐Bing Lin, Karen Miotto, (unknown), Michael R. Irwin, Christopher J. Evans, Lara A. Ray	57
3	Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire 2020 ·American Journal of Respiratory and Critical Care Medicine ·Jeffrey J. Swigris, David Andrae, (unknown), (unknown), Mary Beth Scholand, Eric S. White, (unknown), Karina Raimundo, Christopher J. Evans	28
4	Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability 2020 ·Cellular and Molecular Neurobiology ·Cherkaouia Kibaly, (unknown), Steven Liu, (unknown), Ping‐Yee Law, Christopher J. Evans, Catherine M. Cahill	66
5	A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder 2019 ·Journal of Child and Adolescent Psychopharmacology ·Gianpiera Ceresoli‐Borroni, Tesfaye Liranso, Scott Brittain, Daniel F. Connor, Christopher J. Evans, Robert L. Findling, (unknown), (unknown), Adelaide S. Robb, (unknown), Stefan Schwabe	5
6	Application of the Impulsive Aggression Diary in Adolescents with Attention-Deficit/Hyperactivity Disorder 2019 ·Journal of Child and Adolescent Psychopharmacology ·Gianpiera Ceresoli‐Borroni, Tesfaye Liranso, Scott Brittain, Daniel F. Connor, Christopher J. Evans, Robert L. Findling, (unknown), (unknown), (unknown), Adelaide S. Robb, Keith E. Saylor, (unknown), Stefan Schwabe	3
7	Chronic opioid pretreatment potentiates the sensitization of fear learning by trauma 2019 ·Neuropsychopharmacology ·Zachary T. Pennington, (unknown), Abha K. Rajbhandari, Kevin Li, Wendy Walwyn, Christopher J. Evans, Michael S. Fanselow	12
8	The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence 2018 ·Neuropsychopharmacology ·Kevin Lee, Helen E. Vuong, David J. Nusbaum, Elaine Y. Hsiao, Christopher J. Evans, Anna M.W. Taylor	136
9	Do Words Matter? Patient Perspetives on Conceptually Similar Symptoms and Impacts Frequently Utilized in Patient-Reported Outcome (PRO) Measures 2018 ·Value in Health ·(unknown), (unknown), (unknown), (unknown), (unknown), Christopher J. Evans	1
10	A Screening Tool to Identify Spasticity in Need of Treatment 2016 ·American Journal of Physical Medicine & Rehabilitation ·Richard D. Zorowitz, Theodore Wein, Kari Dunning, Thierry Deltombe, John Olver, (unknown), Michael A. Dimyan, (unknown), Fernando Pagán, Christopher J. Evans, Patrick Gillard, Brett Kissela	9
11	Correlation Between Ventral Striatal Catecholamine Content and Nociceptive Thresholds in Neuropathic Mice 2014 ·Journal of Pain ·Anna M.W. Taylor, Niall Murphy, Christopher J. Evans, Catherine M. Cahill	31
12	Development of a picture guide to identify common postures of spasticity 2014 ·Annals of Physical and Rehabilitation Medicine ·Ib R. Odderson, (unknown), Jörg Wissel, Khashayar Dashtipour, (unknown), Christopher J. Evans, Pieter Gillard, Richard D. Zorowitz	1
13	Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English 2012 ·Health and Quality of Life Outcomes ·Elisabeth Piault, (unknown), (unknown), (unknown), Christopher J. Evans, Agneta Bergqvist, Jeffrey Trocio	15
14	Neurons Preferentially Respond to Self-MHC Class I Allele Products Regardless of Peptide Presented 2009 ·The Journal of Immunology ·Nathalie Escande‐Beillard, Lorraine Washburn, Dan Zekzer, (unknown), (unknown), Sanja Ivković, Yuxin Lu, Hoa Dang, Blake Middleton, Tina Bilousova, Yoshitaka Yoshimura, Christopher J. Evans, Sebastian Joyce, Jide Tian, Daniel L. Kaufman	22
15	Pavlovian conditioning of multiple opioid-like responses in mice 2009 ·Drug and Alcohol Dependence ·Camron D. Bryant, (unknown), (unknown), Alan Le, Christopher J. Evans, Michael S. Fanselow	33
16	The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice 2009 ·Psychopharmacology ·Paul Marquez, (unknown), Vincent Lelièvre, (unknown), Christopher J. Evans, James A. Waschek, Kabirullah Lutfy	24
17	Preliminary development of a responder index for chronic low back pain. 2007 ·PubMed ·Lee S. Simon, Christopher J. Evans, Nathaniel P. Katz, Claire Bombardier, Christine R. West, Jeffery Robbins, Catherine Copley‐Merriman, John D. Markman, John Coombs	29
18	Measurement strategies for indirect costs in economic evaluations 2003 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Christopher J. Evans, Polyxane Mertzanis, Linda Abetz	4
19	The Use of Consensus Methods and Expert Panels in Pharmacoeconomic Studies 1997 ·PharmacoEconomics ·Christopher J. Evans	109
20	Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. 1995 ·Molecular Pharmacology ·(unknown), Paul L. Prather, Horace H. Loh, Ping‐Yee Law, Christopher J. Evans, (unknown)	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact